Carducci, Michael
Shaheen, Montaser
Markman, Ben
Hurvitz, Sara
Mahadevan, Daruka
Kotasek, Dusan
Goodman, Oscar B. Jr
Rasmussen, Erik
Chow, Vincent
Juan, Gloria
Friberg, Gregory R.
Gamelin, Erick
Vogl, Florian D.
Desai, Jayesh
Funding for this research was provided by:
Amgen Inc.
Article History
Received: 9 May 2018
Accepted: 18 June 2018
First Online: 7 July 2018
Compliance with ethical standards
:
: Michael Carducci reports research funding from Amgen to his institution during the conduct of this study. Sara Hurvitz reports a grant from OBI Pharma during the conduct of this study, and grants/research support from Amgen Inc., Bayer, BI Pharma, Genentech, GSK, Lilly, Novartis, Pfizer, Roche, PUMA, Merrimack, Medivation, Dignitana, OBI Pharma, Biomarin, Cascadian, and Seattle Genetics outside the submitted work. Erik Rasmussen, Gloria Juan, Vincent Chow, and Gregory Friberg are employees of Amgen Inc. and hold Amgen stock. Florian Vogl was an employee of Amgen Inc. at the time this work was conducted and holds stock in Amgen Inc. Erick Gamelin was an employee of Amgen Inc. at the time this work was conducted. Jayesh Desai has received research grants from Novartis, Bionomics, and Roche/Genentech and has received fees for consulting from Amgen, Novartis, Bionomics, Lilly, and Eisai. Montaser Shaheen, Ben Markman, Daruka Mahadevan, Dusan Kotasek, and Oscar Goodman declare they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.